Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development
- 31 July 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (21) , 12387-12402
Abstract
The endogenous neuropeptide FF (NPFF) and its two cognate G protein-coupled receptors, Neuropeptide FF Receptors 1 and 2 (NPFFR1 and NPFFR2), represent a relatively new target system for many therapeutic applications including pain regulation, modulation of opioid side effects, drug reward, anxiety, cardiovascular conditions, and other peripheral effects. Since the cloning of NPFFR1 and NPFFR2 in 2000, significant progress has been made to understand their pharmacological roles and interactions with other receptor systems, notably the opioid receptors. A variety of NPFFR ligands with different mechanisms of action (agonists or antagonists) have been discovered although with limited subtype selectivities. Differential pharmacological effects have been observed for many of these NPFFR ligands, depending on assays/models employed and routes of administration. In this Perspective, we highlight the therapeutic potentials, current knowledge gaps, and latest updates of the development of peptidic and small molecule NPFFR ligands as tool compounds and therapeutic candidates.Keywords
Funding Information
- RTI International
- National Institute on Drug Abuse (DA040693, DA045910)
This publication has 113 references indexed in Scilit:
- Neuropeptide FF analog RF9 is not an antagonist of NPFF receptor and decreases food intake in mice after its central and peripheral administrationBrain Research, 2013
- Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatmentsBritish Journal of Pharmacology, 2011
- Opioid‐modulating properties of the neuropeptide FF systemBioFactors, 2010
- The Roles of RFamide‐Related Peptide‐3 in Mammalian Reproductive Function and BehaviourJournal of Neuroendocrinology, 2010
- Neuropeptide FF (NPFF) reduces the expression of cocaine-induced conditioned place preference and cocaine-induced sensitization in animalsPeptides, 2008
- Physical Association between Neuropeptide FF and μ-Opioid Receptors as a Possible Molecular Basis for Anti-opioid ActivityJournal of Biological Chemistry, 2007
- Neuropeptide FF reverses the effect of μ-opioid on Ca2+ channels in rat spinal ganglion neuronesNeuroReport, 1996
- FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the ratPeptides, 1990
- A-18-Famide and F-8-Famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in micePeptides, 1989
- Inhibitory Influences of FMRFamide on Morphine- and Deprivation-Induced FeedingNeuroendocrinology, 1985